Not all specialty drug makers are suffering. Shares of Perrigo (PRGO) are soaring after the drug maker boosted its full-year profit forecast following estimate-beating third quarter results that crushed expectations. “Great quarter on multiple fronts,” wrote Wells Fargo analyst David Maris in a note published today. …The results are a dramatic turnaround from the previous […]